Subscribe To Our Free Newsletter |
Auro Pharma slides as arm’s Telangana facility gets 9 USFDA observations
Aurobindo Pharma declined 1.13% to Rs 1,054.30 after the US drug regulator issued nine observations post inspection at Telangana manufacturing facility of Eugia Pharma Specialities, a wholly owned subsidiary of the company.